Biora Therapeutics, Inc. Financing Cash Flow
Biora Therapeutics, Inc. reported Financing Cash Flow of $17.36 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2024-11-14
- Biora Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-09-30 was $6.62M.
- Biora Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-06-30 was $5.64M, a 26.12% decline year-over-year.
- Biora Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2024-03-31 was $5.10M, a 57.78% decline year-over-year.
- Biora Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2023-12-31 was $13.92M, a 208.19% increase year-over-year.
- Biora Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $30.78M, a 321.77% increase from fiscal 2022.
- Biora Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $7.30M, a 95.58% decline from fiscal 2021.
- Biora Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2021 was $165.05M, a 28.15% decline from fiscal 2020.
- Biora Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2020 was $229.72M, a 211.97% increase from fiscal 2019.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2024-09-30 | $6.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $12.26M derived: sum of 2 quarters · filed 2024-11-14 | $17.36M 10-Q · filed 2024-11-14 | $31.27M derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | $5.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $10.74M 10-Q · filed 2024-08-12 | $24.66M derived: sum of 3 quarters · filed 2024-08-12 | $21.81M derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-03-31 | $5.10M 10-Q · filed 2024-05-15 | $19.02M derived: sum of 2 quarters · filed 2024-05-15 | $16.17M derived: sum of 3 quarters · filed 2024-11-14 | $23.80M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-12-31 | $13.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $11.07M derived: sum of 2 quarters · filed 2024-11-14 | $18.70M derived: sum of 3 quarters · filed 2024-11-14 | $30.78M 10-K · filed 2024-04-01 |
| 2023-09-30 | -$2.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $4.78M derived: sum of 2 quarters · filed 2024-11-14 | $16.86M 10-Q · filed 2024-11-14 | $21.38M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $7.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $19.71M 10-Q · filed 2024-08-12 | $24.23M derived: sum of 3 quarters · filed 2024-08-12 | $22.75M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $12.08M 10-Q · filed 2024-05-15 | $16.60M derived: sum of 2 quarters · filed 2024-05-15 | $15.12M derived: sum of 3 quarters · filed 2024-05-15 | $16.25M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $3.04M derived: sum of 2 quarters · filed 2024-04-01 | $4.16M derived: sum of 3 quarters · filed 2024-04-01 | $7.30M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$352.00K derived: sum of 2 quarters · filed 2023-11-13 | $2.78M 10-Q · filed 2023-11-13 | $76.32M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $4.26M 10-Q · filed 2023-08-14 | $77.80M derived: sum of 3 quarters · filed 2023-08-14 | $109.57M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $3.13M 10-Q · filed 2023-05-15 | $76.67M derived: sum of 2 quarters · filed 2023-05-15 | $108.44M derived: sum of 3 quarters · filed 2023-05-15 | $145.96M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $73.54M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $105.31M derived: sum of 2 quarters · filed 2023-03-30 | $142.82M derived: sum of 3 quarters · filed 2023-03-30 | $165.05M 10-K · filed 2023-03-30 |
| 2021-09-30 | $31.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $69.28M derived: sum of 2 quarters · filed 2022-11-14 | $91.51M 10-Q · filed 2022-11-14 | $195.46M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $37.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $59.74M 10-Q · filed 2022-08-15 | $163.70M derived: sum of 3 quarters · filed 2022-08-15 | $162.86M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $22.23M 10-Q · filed 2022-05-10 | $126.18M derived: sum of 2 quarters · filed 2022-05-10 | $125.35M derived: sum of 3 quarters · filed 2022-05-10 | $241.37M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $103.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $103.12M derived: sum of 2 quarters · filed 2022-03-28 | $219.14M derived: sum of 3 quarters · filed 2022-03-28 | $229.72M 10-K · filed 2022-03-28 |
| 2020-09-30 | -$834.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $115.18M derived: sum of 2 quarters · filed 2021-11-10 | $125.77M 10-Q · filed 2021-11-10 | $179.41M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $116.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $126.60M 10-Q · filed 2021-08-12 | $180.25M derived: sum of 3 quarters · filed 2021-08-12 | $205.01M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $10.58M 10-Q · filed 2021-05-13 | $64.23M derived: sum of 2 quarters · filed 2021-05-13 | $88.99M derived: sum of 3 quarters · filed 2021-05-13 | |
| 2019-12-31 | $53.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $78.41M derived: sum of 2 quarters · filed 2021-03-18 | $73.64M 10-K · filed 2021-03-18 | |
| 2019-09-30 | $24.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $19.99M 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | -$4.77M 10-Q · filed 2020-08-14 |